HARTE HANKS, INC.

HHS ·Industrials, Specialty Business Services, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $159.6M $185.2M $191.5M $206.3M $194.6M $176.9M $217.6M $284.6M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $22.2M $22.8M $20.7M $21.9M $17.9M $21.5M $24.3M
Operating Income $386.0K $2.1M $3.4M $15.1M $7.6M $-10.6M $-21.6M $-26.0M
Operating Margin 0.2% 1.1% 1.8% 7.3% 3.9% -6.0% -9.9% -9.1%
Interest Expense $200.0K $300.0K $500.0K $700.0K $900.0K $200.0K
Pretax Income $-1.0M $-37.9M $-1.9M $19.3M $16.3M $-18.3M $-24.5M $-562.0K
Income Tax Expense $-197.0K $-7.6M $-349.0K $-17.5M $1.3M $-16.6M $1.8M $-18.1M
Net Income $-811.0K $-30.3M $-1.6M $36.8M $15.0M $-1.7M $-26.3M $17.6M
Net Margin -0.5% -16.4% -0.8% 17.8% 7.7% -1.0% -12.1% 6.2%
EPS (Basic) $-0.11 $-4.15 $-0.21 $4.98 $1.85 $-0.34 $-4.26 $2.39
EPS (Diluted) $-0.11 $-4.15 $-0.21 $4.75 $1.76 $-0.34 $-4.26 $2.38
Shares Outstanding (Basic) 7.4M 7.3M 7.3M 7.1M 6.8M 6.5M 6.3M 6.2M
Shares Outstanding (Diluted) 7.4M 7.3M 7.3M 7.5M 7.2M 6.5M 6.3M 6.3M
Dividends Per Share
← Newer Page 1 of 3 Older →